Literature DB >> 8132527

Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.

G W Melchior1, C K Castle, R W Murray, W L Blake, D M Dinh, K R Marotti.   

Abstract

Expression of simian cholesteryl ester transfer protein (CETP) in C57BL/6 mice causes the animals' high density lipoprotein (HDL) levels to decrease. The purpose of these studies was to determine how CETP expression caused that reduction. Chemical analysis showed that the HDL of the CETP transgenic mice had about twice as much triglyceride and only about 60% as much cholesteryl ester as the HDL from the C57BL/6 mice. Both strains of mouse had high levels of a circulating lipase. When plasma from the mice was incubated at 37 degrees C for 5 h, the triglycerides in the HDL were hydrolyzed, and apoA-I was shed from the particle. However, apoA-I was shed from the CETP HDL more rapidly than it was shed from the C57BL/6 HDL. Because "free" apoA-I is rapidly cleared by the kidney, increased production of free apoA-I would be expected to shorten the average life span of apoA-I in the mouse. Kinetic analyses indicated that the life span of apoA-I was significantly reduced in the CETP transgenic mice. It was concluded that CETP expression enriched the core of the HDL with triglyceride, which rendered it vulnerable to lipolysis, causing apoA-I to be shed from the particle. That shortened the life span of apoA-I in the CETP mice, which led to lower plasma levels of the protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  CETP does not affect triglyceride production or clearance in APOE*3-Leiden mice.

Authors:  Silvia Bijland; Sjoerd A A van den Berg; Peter J Voshol; Anita M van den Hoek; Hans M G Princen; Louis M Havekes; Patrick C N Rensen; Ko Willems van Dijk
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 2.  Transcription factors as drug targets: opportunities for therapeutic selectivity.

Authors:  T R Butt; S K Karathanasis
Journal:  Gene Expr       Date:  1995

3.  Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men.

Authors:  B Lamarche; K D Uffelman; A Carpentier; J S Cohn; G Steiner; P H Barrett; G F Lewis
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

Review 4.  Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL.

Authors:  Vassilis I Zannis; Angeliki Chroni; Monty Krieger
Journal:  J Mol Med (Berl)       Date:  2006-02-25       Impact factor: 4.599

5.  Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

Authors:  V Atger; M de la Llera Moya; M Bamberger; O Francone; P Cosgrove; A Tall; A Walsh; N Moatti; G Rothblat
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice.

Authors:  Takhar Kasumov; Belinda Willard; Ling Li; Min Li; Heather Conger; Jennifer A Buffa; Stephen Previs; Arthur McCullough; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-06-13       Impact factor: 8.311

8.  Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.

Authors:  S Zhong; I J Goldberg; C Bruce; E Rubin; J L Breslow; A Tall
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma.

Authors:  Y Osono; L A Woollett; K R Marotti; G W Melchior; J M Dietschy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.